Kook-Jin Lim

Title: Kook-Jin Lim: Innovator in Hepatitis B Research

Introduction

Kook-Jin Lim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the purification of hepatitis B viral surface antigens. His innovative approach has the potential to enhance the efficiency of vaccine production and therapeutic applications.

Latest Patents

Kook-Jin Lim holds a patent for a process titled "Process for purifying hepatitis B viral surface antigen comprising pres2 peptide." This patent describes a method that involves disrupting cells using a buffer containing a chaotropic salt to obtain a cell homogenate. The process further includes alkalifying the cell homogenate to a pH ranging from 11.0 to 13.5, which is crucial for the purification of the viral surface antigen.

Career Highlights

Lim is currently associated with LG Chemical Ltd., a leading company in the chemical and biotechnology sectors. His work at LG Chemical has allowed him to focus on innovative solutions that address critical health challenges. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Kook-Jin Lim has collaborated with esteemed colleagues, including Soon-Jae Park and Young-Mee Lee. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.

Conclusion

Kook-Jin Lim's contributions to hepatitis B research exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at LG Chemical Ltd. highlight the importance of scientific advancements in improving public health.